BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8632454)

  • 1. Comparison of the (30-51, 14-38) two-disulphide folding intermediates of the homologous proteins dendrotoxin K and bovine pancreatic trypsin inhibitor by two-dimensional 1H nuclear magnetic resonance.
    Kortemme T; Hollecker M; Kemmink J; Creighton TE
    J Mol Biol; 1996 Mar; 257(1):188-98. PubMed ID: 8632454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: compartmentalization of folding intermediates and identification of kinetic traps.
    Chang JY; Li L
    Arch Biochem Biophys; 2005 May; 437(1):85-95. PubMed ID: 15820220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements.
    van Mierlo CP; Darby NJ; Keeler J; Neuhaus D; Creighton TE
    J Mol Biol; 1993 Feb; 229(4):1125-46. PubMed ID: 7680380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes.
    Creighton TE; Bagley CJ; Cooper L; Darby NJ; Freedman RB; Kemmink J; Sheikh A
    J Mol Biol; 1993 Aug; 232(4):1176-96. PubMed ID: 7690407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H NMR analysis of the partly-folded non-native two-disulphide intermediates (30-51,5-14) and (30-51,5-38) in the folding pathway of bovine pancreatic trypsin inhibitor.
    van Mierlo CP; Kemmink J; Neuhaus D; Darby NJ; Creighton TE
    J Mol Biol; 1994 Jan; 235(3):1044-61. PubMed ID: 7507172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a subdomain in the folding of bovine pancreatic trypsin inhibitor.
    Staley JP; Kim PS
    Nature; 1990 Apr; 344(6267):685-8. PubMed ID: 1691452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (14-38, 30-51) double-disulphide intermediate in folding of bovine pancreatic trypsin inhibitor: a two-dimensional 1H nuclear magnetic resonance study.
    van Mierlo CP; Darby NJ; Neuhaus D; Creighton TE
    J Mol Biol; 1991 Nov; 222(2):353-71. PubMed ID: 1960731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulphide-coupled protein folding pathways.
    Creighton T
    Philos Trans R Soc Lond B Biol Sci; 1995 Apr; 348(1323):5-10. PubMed ID: 7770487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor. Forming the first disulphide bonds in analogues of the reduced protein.
    Darby NJ; Creighton TE
    J Mol Biol; 1993 Aug; 232(3):873-96. PubMed ID: 7689114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformation of native, reduced and [5-55]Ala bovine pancreatic trypsin inhibitor in the gas phase.
    Nesatiy V; Chen YL; Collings BA; Douglas DJ
    Rapid Commun Mass Spectrom; 1998; 12(1):40-4. PubMed ID: 9450353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional 1H nuclear magnetic resonance study of the (5-55) single-disulphide folding intermediate of bovine pancreatic trypsin inhibitor.
    van Mierlo CP; Darby NJ; Neuhaus D; Creighton TE
    J Mol Biol; 1991 Nov; 222(2):373-90. PubMed ID: 1960732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local conformations of peptides representing the entire sequence of bovine pancreatic trypsin inhibitor and their roles in folding.
    Kemmink J; Creighton TE
    J Mol Biol; 1993 Dec; 234(3):861-78. PubMed ID: 7504737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates.
    Darby NJ; Morin PE; Talbo G; Creighton TE
    J Mol Biol; 1995 Jun; 249(2):463-77. PubMed ID: 7540214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and heterogeneity of the one- and two-disulfide folding intermediates of tick anticoagulant peptide.
    Chang JY; Ballatore A
    J Protein Chem; 2000 May; 19(4):299-310. PubMed ID: 11043935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability.
    Kowalski JM; Parekh RN; Wittrup KD
    Biochemistry; 1998 Feb; 37(5):1264-73. PubMed ID: 9477952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phi-values for BPTI folding intermediates and implications for transition state analysis.
    Bulaj G; Goldenberg DP
    Nat Struct Biol; 2001 Apr; 8(4):326-30. PubMed ID: 11276252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially folded bovine pancreatic trypsin inhibitor analogues attain fully native structures when co-crystallized with S195A rat trypsin.
    Getun IV; Brown CK; Tulla-Puche J; Ohlendorf D; Woodward C; Barany G
    J Mol Biol; 2008 Jan; 375(3):812-23. PubMed ID: 18054043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native-like conformations are sampled by partially folded and disordered variants of bovine pancreatic trypsin inhibitor.
    Tulla-Puche J; Getun IV; Woodward C; Barany G
    Biochemistry; 2004 Feb; 43(6):1591-8. PubMed ID: 14769035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.